Search Results
Feb 13, 2026, 22:19 ET Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Feb 13, 2026, 17:36 ET QURE Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against uniQure N.V.
N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.
More news about: Robbins LLP
Feb 13, 2026, 16:53 ET EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA® VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
https://www.ema.europa.eu/en/news/first-treatment-recommended-rare-immunoglobulin-related-autoimmune-disease. Abgerufen: Februar 2026.Stone JH, Khosroshahi A, Zhang W, et al. Inebilizumab for Treatment
More news about: Amgen
Feb 13, 2026, 16:01 ET AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions.Amgen has been
More news about: Amgen
Feb 13, 2026, 14:41 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK UPLIZNA® OD SPOLOČNOSTI AMGEN NA LIEČBU GENERALIZOVANEJ MYASTÉNIE GRAVIS
https://www.ema.europa.eu/en/news/first-treatment-recommended-rare-immunoglobulin-related-autoimmune-disease. Prístup: Február 2026.Stone JH, Khosroshahi A, Zhang W a kol. Inebilizumab na liečbu
More news about: Amgen
Feb 13, 2026, 13:13 ET NEW ACHIEVEMENT! PLAYMATES TOYS DEBUTS "DUNGEON CRAWLER CARL" COLLECTIBLES AT TOY FAIR 2026
goblins and other supporting characters. Additional featured collectibles will include bronze, silver, and gold loot boxes, which will come in common and rare variations.Crawler fans can purchase the first wave that will debut at San Diego Comic Con this summer, followed by select specialty retailers
More news about: Playmates Toys, Inc.
Feb 13, 2026, 12:20 ET In HelloNation, Watch Expert Bernard Gamache Shares Timeless Advice on Elegant Watch Design
sophistication: deliberate choices, subtle impact, and a focus on meaning over flash.In a fast-paced world, choosing to wear something timeless is a rare act of restraint and clarity. Gamache believes that's part of why luxury watches remain in demand among those who value intention over impulse. A luxury
More news about: HelloNation
Feb 13, 2026, 11:47 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN UPLIZNA ® ДЛЯ ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАННОЙ МИАСТЕНИИ
https://www.ema.europa.eu/en/news/first-treatment-recommended-rare-immunoglobulin-related-autoimmune-disease. Доступно: февраль 2026 года.Stone JH, Khosroshahi A, Zhang W, et al. Inebilizumab for
More news about: Amgen
Feb 13, 2026, 11:41 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK UPLIZNA® SPOLEČNOSTI AMGEN PRO GENERALIZOVANOU MYASTENII GRAVIS
gravis. N Engl J Med. (2025) 392 / (23) 2309-2320Evropská agentura pro léčivé přípravky. First treatment recommended for rare immunoglobulin-related autoimmune disease. K dispozici na
More news about: Amgen
Feb 13, 2026, 11:30 ET Trinitē Road Rally Launches 500-Mile Adventure Motorsport Event
the rally is to celebrate all vehicles and create an egalitarian space within the rally world that welcomes the vehicles in our driveways, not just rare, vintage, or specific brands.The competition is focused on precision driving and navigation, not fastest speed. Participants will experience carefully
More news about: Trinitē Road Rally
Feb 13, 2026, 11:00 ET Brandon McMillan to Appear Live at Global Pet Expo with Exclusive Training Demonstration and Highly Anticipated Product Launch
to pet parents for the first time. Select attendees may even have the opportunity to see their own dogs work with McMillan live on stage, offering a rare, interactive look at elite training techniques in action. This debut marks the first public introduction of a training collection personally designed,
More news about: American Pet Products Association, Inc.
Feb 13, 2026, 11:00 ET Open Pontoon Boat Market Poised for Steady Expansion from USD 1.5 Billion in 2024 to USD 2.3 Billion by 2033, Supported by Rising Recreational Boating Demand : - Market Research Intellect
(Cell and Gene Therapies), Type IV (Vaccines and Immune Modulators), Type V (RNA‑Based Therapeutics)), By Application (Oncology Treatment Channels, Rare Disease Therapeutics, Cell and Gene Therapy Platforms, Respiratory and Immunology Applications, Neuromuscular and Genetic Disorders), Insights, Growth
More news about: Market Research Intellect
Feb 13, 2026, 10:39 ET Electronic Discovery Software Market to Reach USD 10.1 Billion by 2033, Fueled by Rising Digital Litigation, Regulatory Compliance Needs, and Advanced Analytics Adoption: Market Research Intellect
(Cell and Gene Therapies), Type IV (Vaccines and Immune Modulators), Type V (RNA‑Based Therapeutics)), By Application (Oncology Treatment Channels, Rare Disease Therapeutics, Cell and Gene Therapy Platforms, Respiratory and Immunology Applications, Neuromuscular and Genetic Disorders), Insights, Growth
More news about: Market Research Intellect
Feb 13, 2026, 10:05 ET National Wine Day Turns 25: The Republic of Moldova - A Small Country with Global Wine Ambitions
places in the world celebrate wine as a defining element of national identity through an annual national holiday. The Republic of Moldova is among these rare destinations. In 2026, National Wine Day - the country's flagship wine celebration and one of Europe's Top 10 open-air events - marks its 25th anniversary,
More news about: The National Office for Vine and Wine, (Republic of Moldova)
Feb 13, 2026, 09:59 ET National Wine Day Turns 25: The Republic of Moldova - A Small Country with Global Wine Ambitions
places in the world celebrate wine as a defining element of national identity through an annual national holiday. The Republic of Moldova is among these rare destinations. In 2026, National Wine Day - the country's flagship wine celebration and one of Europe's Top 10 open-air events - marks its 25th anniversary,
More news about: The National Office for Vine and Wine, (Republic of Moldova)
Feb 13, 2026, 09:59 ET WORLD PREMIERE OF UNIVERSAL THEME PARKS: THE EXHIBITION OPENS AT THE FRANKLIN INSTITUTE ON FEBRUARY 14
and with Nintendo's iconic Super Mario™ ? Block. Video shorts featuring storyboard artists, lighting designers, prop masters, and others will offer a rare glimpse into the universe of innovation driven by the creative forces that push the boundaries of themed entertainment."The themed entertainment
More news about: The Franklin Institute
Feb 13, 2026, 09:34 ET KOMISJA EUROPEJSKA ZATWIERDZA LEK UPLIZNA® FIRMY AMGEN W LECZENIU UOGÓLNIONEJ MIASTENII
inebilizumabu w uogólnionej miastenii). N Engl J Med. 2025;392(23):2309-2320.European Medicines Agency. First treatment recommended for rare immunoglobulin-related autoimmune disease (Pierwsza terapia rekomendowana w rzadkiej autoimmunologicznej chorobie związanej z immunoglobuliną). Źródło:
More news about: Amgen
Feb 13, 2026, 08:32 ET The Boston Globe to Host Rare Disease Summit
2026 /PRNewswire/ -- The Boston Globe is proud to convene the rare disease community at the second annual Rare Disease Summit on February 24, at 9:30 a.m. ET. Bringing together the individuals and the companies driving innovation in the rare disease space, this Summit will feature special keynote remarks,
More news about: Boston Globe Media
Feb 13, 2026, 08:00 ET Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
formulary review efforts are progressing as planned. We are preparing to expand our field presence to support a highly concentrated prescriber base in this rare cancer setting, supported by an advanced AI-enabled commercial platform designed to drive efficient market penetration," added Mazur."As LYMPHIR
More news about: Citius Oncology, Inc.
Feb 13, 2026, 08:00 ET Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
an AI-enabled commercial platform to support targeted physician engagement and efficient penetration of a highly concentrated prescriber base in this rare oncology market;International patient access advancing: Agreements have been negotiated with regional partners to enable patient access
More news about: Citius Pharmaceuticals, Inc.
Feb 13, 2026, 07:37 ET ICONIC FLORIDA POLO FACILITY HITS THE MARKET
is also comparable in size.Valiente Farm, on every level - privacy, tranquility, flexibility, and ambience stands apart. Truly One of One. A rare opportunity for new stewards to continue their own vision and build upon one of the greatest dreams ever realized in sport.About Valiente
More news about: Icon Global Group, LLC
Feb 13, 2026, 07:37 ET ICONIC FLORIDA POLO FACILITY HITS THE MARKET
is also comparable in size.Valiente Farm, on every level - privacy, tranquility, flexibility, and ambience stands apart. Truly One of One. A rare opportunity for new stewards to continue their own vision and build upon one of the greatest dreams ever realized in sport.About Valiente
More news about: Icon Global Group, LLC
Feb 13, 2026, 06:30 ET Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
Sclerosis, and Transition into a Commercial Organization –– Simona Skerjanec, Former SVP, Global Head of Neuroscience and Rare Diseases at Roche, Elevated to Interim Chairperson of the Board of Directors –– Thor Nagel, Principal at BVF Partners L.P.,
More news about: Immunic, Inc.
Feb 13, 2026, 04:00 ET Gaotu Techedu to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 5, 2026
and drive continuous growth. The Company provides AI-powered, product-led learning solutions for learners from pre-school to adulthood. By combining rare, high-caliber teaching resources with AI-enhanced tools and content, Gaotu creates engaging and effective learning experiences delivered through both
More news about: Gaotu Techedu Inc.
Feb 13, 2026, 01:04 ET HanchorBio Receives FDA Orphan Drug Designation for HCB101 in Gastric Cancer
multinational partners as we explore collaboration and licensing opportunities for HCB101 and our broader immunotherapy pipeline."Gastric cancer is a rare disease in the United States, with prevalence well below the FDA's statutory threshold for orphan designation. Despite advances in targeted therapy
More news about: HanchorBio Inc.